Endometriose und Fertilitätsprotektion – sinnvoll oder nicht?

In: Gynäkologische Endokrinologie · 2019 · vol. 17(2) , pp. 78–82 · doi:10.1007/s10304-019-0248-9 · W2939462131
OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-13 ⓘ

This paper discusses whether fertility protection measures and the optimal timing should be offered to women with endometriosis, which is inherently linked to subfertility due to ovarian damage.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

The paper discusses whether and when women with endometriosis should be offered fertility protection measures, in the context of endometriosis-related subfertility. It explains that inflammatory changes in the pelvic peritoneal environment and the presence of endometriomas/endometriotic cysts can harm the ovarian follicle pool and oocyte quality. As a discussion article, it does not report original human or animal data, and its limitation is that it synthesizes existing evidence rather than providing new empirical results. Relevance to endometriosis: the paper is centrally about endometriosis and specifically addresses fertility protection strategies and optimal timing for affected women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 6,626 characters · extracted from oa-doi-fallback · click to expand
Zusammenfassung Endometriose ist eine der häufigsten gynäkologischen Erkrankungen. Sie ist per se mit dem Risiko der Subfertilität behaftet. Entzündliche Reaktionen in einem veränderten peritonealen Milieu und Endometriome bzw. Endometriosezysten schädigen den Follikelpool der Ovarien und die Eizellqualität. Im vorliegenden Beitrag wird diskutiert, ob es sinnvoll ist, einer Patientin mit Endometriose Maßnahmen der Fertilitätsprotektion anzubieten. Auch auf die Frage nach dem optimalen Zeitpunkt wird dabei eingegangen. Abstract Endometriosis, a common gynecological disease, is inherently associated with subfertility. Inflammatory reactions in the pelvis and endometriomas/endometriotic cysts damage the ovaries and oocytes. In this paper, we discuss if and when routine fertility protection techniques should be offered to women with endometriosis. Similar content being viewed by others Literatur Creux H, Monnier P, Son WY, Buckett W (2018) Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. J Assist Reprod Genet 35:583–592 Brinton LA, Gridley G, Persson I et al (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176:572–579 Vercellini P, Vigano P, Buggio L, Makieva S, Scarfone G, Cribiu FM, Parazzini F, Somigliana E (2018) Perimenopausal Management of ovarian endometriosis and related cancer risk: When is medical or surgical treatment indicated ? Best Pract Res Clin Obstet Gynaecol 51:151–168 Kyama CM, Debrock S, Mwenda JM et al (2003) Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 1:121 Sanchez AM, Stella Vanni V, Bartiromo L, Papaleo E, Zilberberg E, Candiani M, Orvieto R, Vigano P (2017) Ist he oocyte quality affected by endometriosis ? A review of literature. J Ovarian Res 10:43 Brosens I, Puttemans P, Campo R et al (2004) Diagnosis of endometriosis : pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol 18:285–303 Medina MG, Lebovic DI (2009) Endometriosis—associated nerve fibers and pain. Acta Obstet Gynecol Scand 88:968–975 Redwine DB (1999) Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril 72:310–315 Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W, European Society of Human Reproduction and Embryology (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29(3):400–412. https://doi.org/10.1093/humrep/det457 Kohl Schwartz AS, Wölfler MM, Mitter V, Rauchfuss M, Haeberlin F, Eberhard M, von Orelli S, Imthurn B, Imesch P, Fink D, Leeners B (2017) Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril 108(5):806–814.e2. https://doi.org/10.1016/j.fertnstert.2017.08.025 Ulrich U, Buchweitz O, Greb R, Keckstein J, von Leffern I, Oppelt P, Renner SP, Sillem M, Stummvoll W, De Wilde RL, Schweppe KW, German and Austrian Societies for Obstetrics and Gynecology (2014) Leitlinien Endometriose der DGGG (S2k): Leitlinien zur Diagnostik und Therapie der Endometriose. Long Version – AWMF Nr. 015/045. 8/2013. Geburtshilfe Frauenheilkd 74(12):1104–1118 Alborzi S, Momtahan M, Parsanezhad ME, Dehbashi S, Zolghadri J, Alborzi S (2004) A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 82:1633–1637 Hart RJ, Hickey M, Maouris P, Buckett W (2008) Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858 Romualdi D, Franco Zannoni G, Lanzone A, Selvaggi L, Tagliaferri V, gaetano Vellone V (2011) Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations. Fertil Steril 96:374–378 Benschop L, Farquhar C, van der Poel N, Heineman MJ (2010) Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008571.pub2 Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG (2009) The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 92:75–87 Matalliotakis I, Mahutte NG, Koukoura O, Arici A (2006) Endometriosis-associated stage IA clear cell ovarian carcinoma in a woman with IVF-ET treatments in the Yale series. Arch Gynecol Obstet 274:184–186 Moini A, Riazi K, Amid V, Ashrafi M, Tehraninejad E, Madani T, Owj M (2005) Endometriosis may contribute to oocyte retrieval-induced pelvic inflammatory disease: report of eight cases. J Assist Reprod Genet 22:307–309 Peirce CL, Templeman C, Rossing MA, Ovarian cancer Association Consortium (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13:385–394 Carrillo L, Seidmann DS, Cittadini E, Meirow D (2016) The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet 33:317–323 Bianchi PHM, Pereira RMA, Zanatta A, Alegretti JR, Motta ELA, Serafini PC (2009) Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates. J Minim Invasive Gynecol 16:174–180 Pagidas K, Falcone T, Hemmings R, Miron P (1996) Comparison of reoperation for moderate (stage III) and severe (stage IV) endometriosis-related infertility with in vitro fertilization-embryo transfer. Fertil Steril 65:791–795 Author information Authors and Affiliations Corresponding author Ethics declarations Interessenkonflikt W. Küpker, J. Aizpurua und R.E. Felberbaum geben an, dass kein Interessenkonflikt besteht. Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Additional information Redaktion A. Germeyer, Heidelberg R. Felberbaum, Kempten W. Küpker, Bühl Rights and permissions About this article Cite this article Küpker, W., Aizpurua, J. & Felberbaum, R.E. Endometriose und Fertilitätsprotektion – sinnvoll oder nicht?. Gynäkologische Endokrinologie 17, 78–82 (2019). https://doi.org/10.1007/s10304-019-0248-9 Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10304-019-0248-9 Schlüsselwörter - Ovarialendometriose - Endometriosezysten - Weibliche Infertilität - In-vitro-Fertilisation - Chirurgische Therapie der Endometriose

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK